Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0465-2019Class II

Dimension Lipase Flex Reagent Cartridge, Model Number 10460277

Siemens Healthcare Diagnostics Inc. / initiated 2018-09-07 / Terminated

Siemens Healthcare Diagnostics, Inc. began a recall of Dimension Lipase Flex Reagent Cartridge, Model Number 10460277 Product Usage: Dimension - The LIPL method is an in vitro diagnostic test for the quantitative... on . FDA classified it as Class II and gives the reason as "There is lot to lot variability for QC and patient results when using the identified reagent cartridge lots". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-0465-2019
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Siemens Healthcare Diagnostics Inc.
Product
Dimension Lipase Flex Reagent Cartridge, Model Number 10460277 Product Usage: Dimension - The LIPL method is an in vitro diagnostic test for the quantitative measurement of lipase in human serum and plasma on the Dimension clinical chemistry system.
Product code
CHI Lipase-Esterase, Enzymatic, Photometric, Lipase
Reason for recall
There is lot to lot variability for QC and patient results when using the identified reagent cartridge lots.
FDA root cause
Under Investigation by firm
Action
Urgent Medical Device Correction letters dated 9/7/18 were distributed to customers. The letter identified the affected product, problem and actions to be taken. Customers were instructed to complete and return the Field Correction Effectiveness Check Form attached to this letter within 30 days. Please retain this letter with your laboratory records, and forward this letter to those who may have received this product.
Quantity in commerce
18396
Distribution
Worldwide - US Nationwide Distributions The products were distributed to the following foreign countries: Argentina, Australia, Bangladesh, Brazil, Canada, Chile, China, Colombia, Germany, Ecuador, Honduras, Indonesia, India, Japan, Republic of Korea, Mexico, Malaysia, Nicaragua, New Zealand, Peru, Philippines, Paraguay, El Salvador, Thailand, Taiwan, Uruguay and South Africa, Austria, Bahamas, Belgium, Czech Republic, Denmark, , France, , Italy, Netherland, Norway , Portugal, Kuwait, Slovenia, Spain, Switzerland, United Kingdom, Qatar, Republic of Korea, Saudi Arabia, Slovakia, Algeria, Bahrain, Bulgaria, Egypt, , Hungary, Latvia, Lebanon, Lithuania, Macedonia, Nepal, Poland, Romania, Russia Fed, Serbia, Turkey, U.A.E, United Kingdom.
Product codes and lots
Lot Numbers: GD9002, GA9003, GB9032, GA9038

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0465-2019
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0465-2019Class IITerminatedVoluntary: Firm initiated
Z-0466-2019Class IITerminatedVoluntary: Firm initiated